SKF 38393 hydrobromide (Synonyms: (±)-SKF-38393 hydrobromide) |
| Catalog No.GC14048 |
D1-like dopamine receptor partial agonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 20012-10-6
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 20012-10-6 | SDF | |
| Synonyms | (±)-SKF-38393 hydrobromide | ||
| Chemical Name | 1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide | ||
| Canonical SMILES | OC1=C(O)C=C2C(CCNCC2C3=CC=CC=C3)=C1.Br | ||
| Formula | C16H17NO2.HBr | M.Wt | 336.23 |
| Solubility | DMF: 20 mg/ml,DMSO: 20 mg/ml,DMSO:PBS (pH 7.2) (1:20): 0.04 mg/ml,Ethanol: 2 mg/ml | Storage | Desiccate at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.9742 mL | 14.8708 mL | 29.7415 mL |
| 5 mM | 0.5948 mL | 2.9742 mL | 5.9483 mL |
| 10 mM | 0.2974 mL | 1.4871 mL | 2.9742 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC61302 Sulfadimethoxypyrimidine D4
- GC15833 Norharmane
- GC42179 2-methyl-4'-(methylthio)-2-Morpholinopropiophenone
- GC13289 Barnidipine (hydrochloride)
- GC41568 tetranor-PGAM
- GC15296 ML 786 dihydrochloride
- GC35607 Carboxyatractyloside
- GC42735 Adipostatin A
- GC35718 Cnidicin
- GC31094 CR4056
- GC41484 (S)-3'-hydroxy Blebbistatin
- GC39707 Droloxifene
- GC12629 Moxonidine
- GC43398 Defensin HNP-3 (human) (trifluoroacetate salt)
- GN10211 Salvianolic acid A
- GC12833 Solithromycin
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *